Insider · CIK 0001321402

RAAB MICHAEL

Reports to the SEC for 4 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001321402

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−15K sh	$3.86	−$57.9K	1,663,357
2026-08-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−16K sh	$3.86	−$61.6K	1,647,381
2026-08-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−8,411 sh	$3.86	−$32.4K	1,638,970
2026-08-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−19.2K sh	$3.86	−$74K	1,619,792
2026-07-15	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,720,034
2026-07-15	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−41.7K sh	$5.06	−$211K	1,678,366
2026-07-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−20.8K sh	—	—	290,834
2026-06-15	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,740,866
2026-06-15	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−41.7K sh	$5.67	−$236K	1,699,200
2026-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−20.8K sh	—	—	311,668
2026-05-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−14.9K sh	$6.27	−$93.6K	1,759,848
2026-05-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−7,861 sh	$6.27	−$49.3K	1,751,987
2026-05-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−17.9K sh	$6.27	−$112K	1,734,061
2026-05-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−14K sh	$6.27	−$87.9K	1,720,033
2026-05-15	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,816,447
2026-05-15	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−41.7K sh	$6.28	−$262K	1,774,781
2026-05-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−20.8K sh	—	—	332,501
2026-04-27	AMICUS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−116K sh	$14.50	−$1.68M	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.2K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.6K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.1K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.4K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−74.9K sh	—	—	0
2026-04-15	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,837,282
2026-04-15	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−41.7K sh	$6.29	−$262K	1,795,614
2026-04-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−20.8K sh	—	—	353,334
2026-03-16	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,856,986
2026-03-16	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−41.7K sh	$5.84	−$243K	1,816,448
2026-03-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−20.8K sh	—	—	374,168
2026-02-24	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,877,819
2026-02-24	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−41.7K sh	$6.25	−$261K	1,836,153
2026-02-24	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−20.8K sh	—	—	395,001
2026-02-20	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−40.4K sh	$5.87	−$237K	1,862,567
2026-02-20	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−5,576 sh	$5.71	−$31.9K	1,856,991
2026-02-20	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−2 sh	$5.70	−$11.401	1,856,989
2026-02-20	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−1 sh	$5.70	−$5.703	1,856,988
2026-02-20	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−2 sh	$5.70	−$11.401	1,856,986
2026-01-27	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,230 sh	—	—	1,230
2026-01-23	ARDXARDELYX, INC.A Award	Director, President & CEO	AAward	+446K sh	—	—	1,902,968
2026-01-23	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+669K sh	—	—	669,330
2025-11-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−46.9K sh	$5.54	−$260K	1,455,363
2025-08-21	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−45.7K sh	$5.93	−$271K	1,502,250
2025-06-05	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+20.4K sh	—	—	115,857
2025-06-05	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+74.9K sh	—	—	74,872
2025-05-20	ARDXARDELYX, INC.S Sale	Director, President & CEO	SSale	−46.8K sh	$4.08	−$191K	1,547,937
2025-05-02	ARDXARDELYX, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+20.8K sh	$0.99	+$20.6K	1,636,420

Recent filings

Accepted (ET)
Aug 254
RAAB MICHAEL0001321402-26-000019
SEC(opens sec.gov)
Jul 174
RAAB MICHAEL0001321402-26-000016
SEC(opens sec.gov)
Jun 174
RAAB MICHAEL0001321402-26-000014
SEC(opens sec.gov)
May 224
RAAB MICHAEL0001321402-26-000012
SEC(opens sec.gov)
May 194
RAAB MICHAEL0001321402-26-000009
SEC(opens sec.gov)
Apr 274
RAAB MICHAEL0001193125-26-182264
SEC(opens sec.gov)

Companies

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451